151 related articles for article (PubMed ID: 32868539)
21. Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression.
Mohammed A; F K Alghetaa H; Miranda K; Wilson K; P Singh N; Cai G; Putluri N; Nagarkatti P; Nagarkatti M
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872332
[TBL] [Abstract][Full Text] [Related]
22. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia.
Zhou W; Liu Y; Tian D; Wang C; Wang S; Cheng J; Hu M; Fang M; Gao Y
Signal Transduct Target Ther; 2020 Feb; 5(1):18. PubMed ID: 32296012
[No Abstract] [Full Text] [Related]
23. Respiratory Mechanics of COVID-19- versus Non-COVID-19-associated Acute Respiratory Distress Syndrome.
Haudebourg AF; Perier F; Tuffet S; de Prost N; Razazi K; Mekontso Dessap A; Carteaux G
Am J Respir Crit Care Med; 2020 Jul; 202(2):287-290. PubMed ID: 32479162
[No Abstract] [Full Text] [Related]
24. Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management.
Matucci-Cerinic M; Bruni C; Allanore Y; Clementi M; Dagna L; Damjanov NS; de Paulis A; Denton CP; Distler O; Fox D; Furst DE; Khanna D; Krieg T; Kuwana M; Lee EB; Li M; Pillai S; Wang Y; Zeng X; Taliani G
Ann Rheum Dis; 2020 Jun; 79(6):724-726. PubMed ID: 32349982
[TBL] [Abstract][Full Text] [Related]
25. Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19).
Lohse A; Klopfenstein T; Balblanc JC; Royer PY; Bossert M; Gendrin V; Charpentier A; Bozgan AM; Badie J; Bourgoin C; Contreras R; Mazurier I; Conrozier T; Zayet S
Microbes Infect; 2020 Oct; 22(9):500-503. PubMed ID: 32574789
[TBL] [Abstract][Full Text] [Related]
26. Vitamin C levels in patients with SARS-CoV-2-associated acute respiratory distress syndrome.
Chiscano-Camón L; Ruiz-Rodriguez JC; Ruiz-Sanmartin A; Roca O; Ferrer R
Crit Care; 2020 Aug; 24(1):522. PubMed ID: 32847620
[No Abstract] [Full Text] [Related]
27. Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer.
Barbieri A; Robinson N; Palma G; Maurea N; Desiderio V; Botti G
Front Immunol; 2020; 11():588724. PubMed ID: 33117402
[TBL] [Abstract][Full Text] [Related]
28. Acute respiratory distress syndrome and steroids in the shadow of coronavirus disease 2019.
Jaeschke R
Pol Arch Intern Med; 2020 Apr; 130(4):266-267. PubMed ID: 32383835
[No Abstract] [Full Text] [Related]
29. Case Report: Canakinumab for the Treatment of a Patient With COVID-19 Acute Respiratory Distress Syndrome.
Caracciolo M; Macheda S; Labate D; Tescione M; La Scala S; Vadalà E; Squillaci R; D'Aleo F; Morabito A; Garreffa C; Marciano MC; Oliva EN
Front Immunol; 2020; 11():1942. PubMed ID: 32983123
[TBL] [Abstract][Full Text] [Related]
30. Circulating Plasminogen Concentration at Admission in Patients with Coronavirus Disease 2019 (COVID-19).
Henry BM; Benoit SW; Hoehn J; Lippi G; Favaloro EJ; Benoit JL
Semin Thromb Hemost; 2020 Oct; 46(7):859-862. PubMed ID: 32882718
[No Abstract] [Full Text] [Related]
31. Oxygenation device with reservoir and PEEP (ODRPEEP) in patients with acute respiratory distress due to COVID-19.
Segura Alba O; Nieto Fernández-Pacheco A; Pardo Ríos M
Med Clin (Barc); 2020 Aug; 155(3):133-134. PubMed ID: 32482415
[No Abstract] [Full Text] [Related]
32. Unexpected BP Sensitivity to Angiotensin II in a Patient With Coronavirus Disease 2019, ARDS, and Septic Shock.
Wang H; Das S; Wieruszewski PM; Taji J; Bartlett B; Azad N; Chowdhury A; Kolar GJ; Jain N; Subla MR; Khan SA
Chest; 2020 Aug; 158(2):e55-e58. PubMed ID: 32335068
[TBL] [Abstract][Full Text] [Related]
33. Lung Recruitability in COVID-19-associated Acute Respiratory Distress Syndrome: A Single-Center Observational Study.
Pan C; Chen L; Lu C; Zhang W; Xia JA; Sklar MC; Du B; Brochard L; Qiu H
Am J Respir Crit Care Med; 2020 May; 201(10):1294-1297. PubMed ID: 32200645
[No Abstract] [Full Text] [Related]
34. Neutrophil Elastase Inhibitors: A potential prophylactic treatment option for SARS-CoV-2-induced respiratory complications?
Mohamed MMA; El-Shimy IA; Hadi MA
Crit Care; 2020 Jun; 24(1):311. PubMed ID: 32513225
[No Abstract] [Full Text] [Related]
35. The Effect of Anticoagulation Use on Mortality in COVID-19 Infection.
Salah HM; Naser JA; Calcaterra G; Bassareo PP; Mehta JL
Am J Cardiol; 2020 Nov; 134():155-157. PubMed ID: 32892991
[No Abstract] [Full Text] [Related]
36. Hemostasis profile in COVID-19 infection.
Duarte FB; Machado RPG; Lemes RPG; Duarte IA; Duarte BA; Machado CMG; Duarte JVA; Rocha SGMD; Moura ATG; Holanda RARR
Rev Assoc Med Bras (1992); 2020 May; 66(5):571-572. PubMed ID: 32638971
[No Abstract] [Full Text] [Related]
37. Countermeasure and therapeutic: A(1-7) to treat acute respiratory distress syndrome due to COVID-19 infection.
Soto M; diZerega G; Rodgers KE
J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320972018. PubMed ID: 33169644
[TBL] [Abstract][Full Text] [Related]
38. Early outcomes with utilization of tissue plasminogen activator in COVID-19-associated respiratory distress: A series of five cases.
Christie DB; Nemec HM; Scott AM; Buchanan JT; Franklin CM; Ahmed A; Khan MS; Callender CW; James EA; Christie AB; Ashley DW
J Trauma Acute Care Surg; 2020 Sep; 89(3):448-452. PubMed ID: 32427774
[TBL] [Abstract][Full Text] [Related]
39. Physiological Changes During Prone Positioning in COVID-19 Acute Respiratory Distress Syndrome.
Lee RM; Tan GP; Puah SH; Ling LM; Choy CY; Chotirmall SH; Abisheganaden J; See JJ; Tan HL; Wong YL
Ann Acad Med Singap; 2020 Jul; 49(7):509-513. PubMed ID: 33000116
[No Abstract] [Full Text] [Related]
40. Effect of almitrine bismesylate and inhaled nitric oxide on oxygenation in COVID-19 acute respiratory distress syndrome.
Cardinale M; Esnault P; Cotte J; Cungi PJ; Goutorbe P
Anaesth Crit Care Pain Med; 2020 Aug; 39(4):471-472. PubMed ID: 32505755
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
